Intellia Therapeutics
NTLA
#4597
Rank
HK$13.21 B
Marketcap
HK$130.07
Share price
4.56%
Change (1 day)
-33.27%
Change (1 year)

Earnings for Intellia Therapeutics (NTLA)

Earnings in 2024 (TTM): -HK$3.98 Billion

According to Intellia Therapeutics's latest financial reports the company's current earnings are HK$45.96 Million. In 2023 the company made an earning of -HK$3.75 Billion a decrease over its 2022 earnings that were of -HK$3.69 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Intellia Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$3.98 Billion6.33%
2023 -HK$3.75 Billion1.48%
2022 -HK$3.69 Billion77.01%
2021 -HK$2.09 Billion99.58%
2020 -HK$1.05 Billion34.86%
2019 -HK$0.78 Billion16.63%
2018 -HK$0.67 Billion26.35%
2017 -HK$0.53 Billion113.51%
2016 -HK$0.25 Billion135.92%
2015 -HK$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$0.98 Billion-75.41%๐Ÿ‡บ๐Ÿ‡ธ USA